Watch stocks you care about
The single, easiest way to keep track of all the stocks that matter...
Your own personalized stock watchlist!
It's a 100% FREE Motley Fool service...
Defensive shares have had a terrific run in this bull market -- to the point where some commentators are beginning to say that the run must surely be coming to an end. However, if you believe high-profile activist investor Bill Ackman, there is at least one prominent defensive stock which has plenty of outperformance ahead of it: Dow Jones Industrial Average component Procter & Gamble (NYSE: PG ) .
Speaking at the Ira Sohn Investment Conference, Ackman called P&G one of the "great businesses of the world," and said it could be worth $125 in two years' time. How did he arrive at that figure? Ackman believes the company should be able to grow at 5% a year, and could trade at a forward price-to-earnings multiple of 20 by June 2015, enough to produce a $120 share price. Add an estimated $5 in dividends, and you have your $125 intrinsic value.
Ackman has already put his money where his mouth is with a roughly $2 billion stake in the firm. To verify whether he's onto something or just talking his book, the following chart displays the price performance of Procter & Gamble shares versus that of the S&P 500, as well as the progression in P&G's price-to-earnings ratio, all starting from the bear market bottom on March 9, 2009:
Two remarks are in order:
First, Procter & Gamble has badly underperformed the index in the current bull market, which suggests that outperformance over the next several years isn't a far-fetched notion (assuming you believe the business isn't in terminal decline.) Mean reversion is a genuine phenomenon.
Second, while the majority of the S&P 500's gains are attributable to an increase in earnings rather than an increase in the valuation multiple, the reverse is true of P&G. Indeed, the S&P 500's trailing 12-months' operating earnings per share are up 99%, better than two-thirds of the 141% rise in the index.
Meanwhile, the graph shows the difference in the change in P&G's share price, and the change in its price-to-earnings ratio is roughly five percentage points. Sure enough, the change in the company's normalized earnings per share over the same period is less than 6%. (Total, not annualized!) Assuming the company can jump-start its earnings, the shares could benefit from a two-fold boost if the market is willing to attribute a higher multiple to those earnings. That, in turn, suggests strong returns are possible -- even plausible.